October 13, 2025
- Logista Pharma and Ascendis Pharma, S.L. sign a strategic agreement for hospital distribution of Palopegteriparatide
Logista Pharma, a leader in specialized pharmaceutical distribution, has signed a strategic agreement with the Danish biopharmaceutical company Ascendis Pharma Iberia, S.L. for the hospital distribution of Yorvipath® (palopegteriparatide), a treatment for chronic hypoparathyroidism, a rare endocrine disease.
Logista Pharma will be responsible for the storage, order preparation, and subsequent delivery of Ascendis Pharma Iberia, S.L. products to hospitals. This partnership strengthens Logista Pharma’s growth in hospital drug distribution.
This agreement will ensure that palopegteriparatide—approved by European and U.S. regulatory authorities and recently authorized for commercialization in Spain—reaches hospitals efficiently and safely, guaranteeing patient access to a treatment that directly addresses the underlying cause of chronic hypoparathyroidism.
A key step in the treatment of rare diseases
The drug, developed as TransCon PTH, is the first approved treatment that provides continuous exposure to parathyroid hormone (PTH) over 24 hours, enabling better regulation of calcium, phosphorus, and active vitamin D in patients with chronic hypoparathyroidism. This disease affects around 13,000 people in Spain and presents neuromuscular, renal, and cognitive complications. Most cases (between 70% and 80%) result from complications following thyroid surgery.
A Strategic Agreement with Positive Impact
This agreement reinforces both companies’ commitment to improving the quality of life for patients with rare diseases. The alliance combines Ascendis Pharma Iberia, S.L.’s therapeutic innovation with Logista Pharma’s logistical capabilities and hospital expertise, ensuring effective and safe distribution of the drug throughout Spain.
“We are proud to collaborate with Ascendis Pharma Iberia, S.L. in the distribution of such an innovative medicine. This agreement reflects our commitment to facilitating access to cutting-edge treatments for rare diseases,” said Ignacio Sánchez Caballero, General Manager of Logista Pharma.
Sobre Logista Pharma - logistapharma.com
Logista Pharma is Logista’s specialized pharmaceutical distribution company serving all pharmaceutical channels in Spain, Portugal, and Italy. It offers the broadest range of services to meet the needs of the pharmaceutical industry. With a high-precision logistics network and services tailored to the healthcare sector, it ensures traceability, safety, and regulatory compliance in the distribution of all products. Logista Pharma currently works with over 250 pharmaceutical laboratories.
Logista Pharma relies on the group’s transport companies for order deliveries, ensuring full operational integration, real-time physical and thermal traceability, the highest quality standards, and the use of cutting-edge information systems.
About Logista - logista.com
Logista is one of the largest logistics operators in Europe, specializing in distribution to proximity channels. It regularly serves around 200,000 points of sale in Spain, France, Italy, Portugal, the Netherlands, Belgium, and Poland, providing the best and fastest market access for a wide range of products including convenience items, pharmaceuticals, electronic top-ups, books, publications, tobacco, and lotteries, among others. It also boasts the largest transport network in Spain, certified in food safety.
Logista has a highly qualified team of over 8,000 direct employees and a large number of collaborators, such as Nacex franchisees, Logista Parcel delegates, drivers, etc. Employees and collaborators are all focused on serving customers in the most efficient and tailored way possible.